Wednesday, July 8, 2026

biotech · Systemic Lupus Erythematosus · Primary Progressive Multiple Sclerosis (PPMS) · ZBIO

Zenas BioPharma

News and analysis for Zenas BioPharma on NovaPharmaNews — regulatory, clinical, and market coverage.

1000 Winter St, Suite 1200, Waltham, MA 02451, US HQ
176 Employees
Public company Type
ZBIO · NYSE Ticker
Company details
Status
Public
HQ
1000 Winter St, Suite 1200, Waltham, MA 02451, US
Employees
176
Programs
13
Drugs
10
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Zenas BioPharma — regulatory, clinical, and market coverage.

News and analysis for Zenas BioPharma on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Zenas BioPharma yet.

Back to company overview →